Farther Finance Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.14K | Sell |
93
-296
| -76% | -$16.4K | ﹤0.01% | 3339 |
|
|
2025
Q1 | $18.2K | Buy |
389
+345
| +784% | +$16.2K | ﹤0.01% | 2425 |
|
|
2024
Q4 | $1.7K | Hold |
44
| – | – | ﹤0.01% | 3057 |
|
|
2024
Q3 | $1.98K | Sell |
44
-1
| -2% | -$45 | ﹤0.01% | 2993 |
|
|
2024
Q2 | $1.58K | Buy |
45
+5
| +13% | +$176 | ﹤0.01% | 2884 |
|
|
2024
Q1 | $1.13K | Hold |
40
| – | – | ﹤0.01% | 2723 |
|
|
2023
Q4 | $917 | Buy |
+40
| New | +$917 | ﹤0.01% | 2771 |
|